Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

While there have been advances in the treatment of hormone-driven breast cancer, resistance to these therapies remains a significant problem.

21 Nov 2016

Scientists reveal key details of the body's immune response to fungal infections

Every year, fungal infections threaten thousands of patients -- from those with depressed immune systems to others who have had surgeries or devices such as catheters implanted. Moreover, some anti-fungal medications are beginning to lose their power.

17 Nov 2016

Psoriatic arthritis patients experience multiple symptoms that can make diagnosis difficult, survey reveals

Psoriatic arthritis (PsA) is an inflammatory condition closely related to and most often co-occurring with psoriasis.

16 Nov 2016

TSRI study reveals how circadian clocks may influence cancer growth

A new study led by scientists at The Scripps Research Institute describes an unexpected role for proteins involved with our daily "circadian" clocks in influencing cancer growth.

16 Nov 2016

Children born to mothers with rheumatoid arthritis may have increased risk of developing epilepsy

A new study shows a link between mothers with rheumatoid arthritis and children with epilepsy.

16 Nov 2016

Smoking, excess weight may influence how rheumatoid arthritis symptoms improve with treatment

A study finds that smoking or being overweight makes it more difficult for patients with rheumatoid arthritis to achieve optimal control of inflammation and symptoms, despite standard of care treatment.

16 Nov 2016

CreakyJoints announces first patient-friendly guidelines for rheumatoid arthritis

CreakyJoints, the go-to source for more than 100,000 arthritis patients and their families world-wide who are seeking education, support, advocacy, and patient-centered research, today announced the forthcoming publication of “A Patient’s Guide to Living with Rheumatoid Arthritis.”

15 Nov 2016

TSRI study unravels how protein is directly responsible for sensing touch

A new study led by scientists at The Scripps Research Institute reveals that a protein first discovered at TSRI in 2010 is directly responsible for sensing touch.

14 Nov 2016

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

A new study led by scientists at The Scripps Research Institute suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages.

11 Nov 2016

New Australian research shows how immune system avoids attacking own tissues with antibodies

New Australian research has shown how the immune system avoids attacking its own tissues with antibodies - whilst still maintaining a strong defence against invaders.

11 Nov 2016

TSRI scientists receive NIH grants for computational biology research

Three groups at The Scripps Research Institute have been awarded grants from the National Institutes of Health to develop methods for computational modeling and to apply them to cutting-edge systems in biology and health.

10 Nov 2016

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs.

8 Nov 2016

Biologic drugs may help prevent progressive bone loss in patients with RA

A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.

7 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

TSRI scientists develop useful technique to unmask new functional features of human proteins

Scientists at The Scripps Research Institute have developed a broadly useful method to unmask new functional features of human proteins.

1 Nov 2016

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma

The prognosis for patients diagnosed with scleroderma - an autoimmune disease characterized by fibrosis of the skin - is not typically a rosy one. With limited treatment options available, those suffering from the disorder can face disabling hardening and tightening of their skin.

31 Oct 2016

Researchers develop new blood test for diagnosis of early-stage osteoarthritis

Patients could soon be diagnosed with early-stage arthritis several years before the onset of physical and irreversible symptoms, thanks to a new test developed by researchers at the University of Warwick.

27 Oct 2016

Two leading non-profit organizations sign strategic affiliation to hasten drug development

The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

20 Oct 2016

U-M investigators awarded $7.5 million NIH grant to expand chronic pain research

In order to better understand the disparity between identifiable damage and chronic pain, the National Institutes of Health has awarded $7.5 million over five years to physician-scientists at the University of Michigan Health System.

19 Oct 2016

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Anti-inflammatory drugs similar to those used to treat conditions such as rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression, concludes a review led by the University of Cambridge, which further implicates our immune system in mental health disorders.

18 Oct 2016

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

Scientists reveal key details of the body's immune response to fungal infections

Psoriatic arthritis patients experience multiple symptoms that can make diagnosis difficult, survey reveals

TSRI study reveals how circadian clocks may influence cancer growth

Children born to mothers with rheumatoid arthritis may have increased risk of developing epilepsy

Smoking, excess weight may influence how rheumatoid arthritis symptoms improve with treatment

CreakyJoints announces first patient-friendly guidelines for rheumatoid arthritis

TSRI study unravels how protein is directly responsible for sensing touch

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

New Australian research shows how immune system avoids attacking own tissues with antibodies

TSRI scientists receive NIH grants for computational biology research

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

Biologic drugs may help prevent progressive bone loss in patients with RA

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

TSRI scientists develop useful technique to unmask new functional features of human proteins

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma

Researchers develop new blood test for diagnosis of early-stage osteoarthritis

Two leading non-profit organizations sign strategic affiliation to hasten drug development

U-M investigators awarded $7.5 million NIH grant to expand chronic pain research

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in